Loading...

Home
ETF
EBS

EBS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

EBS News

Flutter Entertainment Reports Disappointing Q4 Results, Shares Plunge

Feb 27 2026Benzinga

U.S. Stocks Decline Midway; Dell Shares Surge Over 21%

Feb 27 2026Benzinga

Emergent BioSolutions' 2026 Revenue Guidance Falls Short of Expectations

Feb 27 2026seekingalpha

U.S. Stocks Drop Over 600 Points in Morning Trading

Feb 27 2026Benzinga

Emergent BioSolutions Stock Drops 22% Following Decline in Q4 Revenue

Feb 27 2026moomoo

Applied Optoelectronics Reports Strong Q4, Shares Surge

Feb 27 2026Benzinga

Emergent BioSolutions Issues Weaker FY26 Revenue Guidance Below Consensus

Feb 27 2026stocktwits

Emergent BioSolutions Q4 2025 Earnings Call Highlights

Feb 27 2026seekingalpha

Emergent BioSolutions Authorizes New $50 Million Share Repurchase Program

Feb 26 2026seekingalpha

Emergent Biosolutions Set to Announce Q4 Earnings on February 26

Feb 25 2026seekingalpha

Emergent BioSolutions Receives FDA Approval for New NARCAN Multipack Configurations

Feb 13 2026Benzinga

Emergent Receives FDA Approval for New NARCAN® Nasal Spray Multipacks

Feb 12 2026Newsfilter

Emergent BioSolutions Receives FDA Approval for New NARCAN® Nasal Spray Multipacks

Feb 12 2026Yahoo Finance

Emergent BioSolutions (EBS) Sued for Insider Trading, Agrees to $900K Settlement

Jan 16 2026Benzinga

Emergent Biosolutions' Former CEO Sued for Insider Trading, Facing $900,000 Penalty

Jan 15 2026stocktwits

Emergent BioSolutions (EBS) Receives FDA Approval for New NARCAN Nasal Spray Packaging

Jan 14 2026NASDAQ.COM